Journal of Medicinal Chemistry · 2017 · 10 citations · 34 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAnalgesic PharmacologyLigand BindingReceptor ModelingReceptor PharmacologyReceptor-ligand InteractionsStructure-activity Relationship AnalysisChemical Structure-activity RelationshipsReceptor-mediated AnalgesiaSelectivity
Our previous work discovered that combining the appropriate 5′- and N 6 -substitution in adenosine derivatives leads to the highly selective human A 1 adenosine receptor (hA 1 AR) agonists or highly potent dual hA 1 AR agonists and hA 3 AR antagonists. In order to explore novel dual adenosine receptor ligands, a series of N 6 -substituted-5′-pyrazolyl-adenosine and 2-chloro-adenosine derivatives were synthesized and assayed in vitro at all ARs. The N 6 -(±)- endo -norbornyl derivative 12 was the most potent and selective at A 1 AR and effective as an analgesic in formalin test in mice, but none of the 5′-pyrazolyl series compounds showed a dual behavior at hA 1 and hA 3 AR. Molecular modeling studies rationalized the structure–activity relationships and the selectivity profiles of the new series of A 1 AR agonists. Interestingly, an unexpected inverted binding mode of the N 6 -tetrahydrofuranyl derivative 14 was hypothesized to explain its low affinity at A 1 AR.
34
Improved protein–ligand docking using GOLD
Marcel L. Verdonk, Jason C. Cole, Michael J. Hartshorn et al. · Proteins Structure Function and Bioinformatics · 2003 · 3K citations · Full text
The penultimate rotamer library
Simon C. Lovell, J. Michael Word, Jane S. Richardson et al. · Proteins Structure Function and Bioinformatics · 2000 · 1K citations
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Guillaume Lebon, Tony Warne, Patricia C. Edwards et al. · Nature · 2011 · 883 citations · Full text